XBiotech Inc. (XBIT)
NASDAQ: XBIT · Real-Time Price · USD
2.880
+0.020 (0.70%)
At close: Jun 6, 2025, 4:00 PM
2.900
+0.020 (0.69%)
After-hours: Jun 6, 2025, 4:04 PM EDT

XBiotech Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
88120122107338458
Upgrade
Market Cap Growth
-60.10%-1.10%13.95%-68.42%-26.11%-40.29%
Upgrade
Enterprise Value
-67-53-80-11399219
Upgrade
Last Close Price
2.903.954.003.5111.1313.51
Upgrade
Forward PE
-87.6387.6387.6387.6387.63
Upgrade
PS Ratio
---26.6418.3910.41
Upgrade
PB Ratio
0.510.660.560.441.261.31
Upgrade
P/TBV Ratio
0.510.660.560.441.261.31
Upgrade
P/FCF Ratio
----5.13-
Upgrade
P/OCF Ratio
----4.87-
Upgrade
EV/Sales Ratio
----5.414.99
Upgrade
EV/FCF Ratio
----1.51-
Upgrade
Debt / Equity Ratio
-0.06----
Upgrade
Asset Turnover
---0.020.060.08
Upgrade
Quick Ratio
28.9311.4932.9453.9271.2262.26
Upgrade
Current Ratio
29.1511.5633.0754.0771.4981.80
Upgrade
Return on Equity (ROE)
-20.53%-19.21%-10.69%-12.91%-5.63%-2.03%
Upgrade
Return on Assets (ROA)
-13.78%-12.47%-9.92%-8.27%-4.98%-1.95%
Upgrade
Return on Capital (ROIC)
-14.33%-12.90%-10.21%-8.46%-5.07%-2.07%
Upgrade
Earnings Yield
-44.58%-32.00%-20.17%-30.79%-5.15%-2.45%
Upgrade
FCF Yield
-35.77%-26.80%-15.68%-14.42%19.48%-15.04%
Upgrade
Buyback Yield / Dilution
-0.11%-0.07%0.00%-1.32%2.53%33.45%
Upgrade
Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q